Table 2.
Comparisons of Anti-inflammatory Potency and Ocular Penetration of Topical Ocular Glucocorticoids
Glucocorticoid | Relative Anti-inflammatory Activity | Dose | Peak Aqueous Humor Concentration (ng/mL) | Time to Peak (minutes) | IOP Rise (mmHg) |
---|---|---|---|---|---|
Cortisol | 1 | 0.5% | 3.2 | ||
Prednisolone | 4 | 1% | 7650 | 30 | 10.0 |
Prednisolone Acetate | 4 | 1% | 670–1130 | 45–120 | |
Prednisolone Phosphate | 4 | 1% | 26 | 90–240 | |
Fluorometholone | 40 | 0.1% | 5.1 | 30–60 | 6.1 |
Dexamethasone | 25 | 0.1% | 31 | 90–120 | 22.0 |
Dexamethasone Phosphate | 25 | 0.1% | 31 | 55 | |
Medrysone | 4 | 1% | 1.0 | ||
Loteprednol etabonate | 25 | 0.5% | * | * | |
Rimexolone | 25 | 1% | ~6 | ||
Difluprednate emulsion | 60 | 0.05% | 30 | 60 |
Rapidly metabolized and inactivated in cornea (Druzgala P et al. PMID 1959381)[124]
Data from: Murdick PW, Keates RH, Donovan EF et al. (PMID: 5928150)[125]
Awan MA, Agarwal PK, Watson DG et al (PMID: 19293163)[126]
Razeghinejad MR, Katz L (PMID: 21757964)[127]
Yamaguchi M, Yasueda S et al (PMID: 16023810)[128]